Brown Cancer Center News
Scientists are Recognized by Metro Council
Louisville’s Metro Council recognized world-renowned James Graham Brown Cancer Center researchers Alfred Bennett “Ben” Jenson, MD and Shin-Je Ghim, PhD on Thursday, August 17 for their “outstanding contribution as inventors of the world’s first cervical cancer vaccine.” Councilwoman Mary C. Woolridge (3rd District) made the presentation on behalf of the Metro Council.
Jenson and Ghim helped invent the human papillomavirus (HPV)/cervical cancer vaccine that was recently approved by the FDA and recommended for vaccination by the CDC’s Advisory Committee. It is the world’s first 100 percent effective vaccine against cervical cancer. The vaccine, Gardasil®, being developed and marketed by Merck & Co. and is already on the market.
Earlier this summer, Jenson presented background on the team’s discovery and focus of their current research at the Brown Cancer Center to the Health and Human Services Committee, at Councilwoman Woolridge’s request. She later decided that a public recognition of Jenson and Ghim’s monumental contribution to the fight against cervical cancer was much deserved.
The James Graham Brown Cancer Center is a key component of the University of Louisville’s Health Sciences Center and UofL Health Care. As the region’s leading academic, research, and teaching medical center, our patients benefit from the latest medical advances, often long before they become available in non-teaching settings. The Brown Cancer Center is affiliated with the National Cancer Institute and the Kentucky Cancer Program. It is the only cancer center in the region to use a unified approach to cancer care, with multidisciplinary teams of physicians working together to guide patients through diagnosis, treatment and recovery.
Related Stories:
The James Graham Brown Cancer Center
Inventors Praise FDA Approval of Cervical Cancer Vaccine
News Archive